A seven-microRNA expression signature predicts survival in hepatocellular carcinoma

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Zhang, Jian ^a   Chong, Charing C N ^a   Chen, George G ^a   Lai, Paul B S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 30D; MICRORNA 326; MICRORNA 3677; MICRORNA 511 1; MICRORNA 511 2; MICRORNA 9 1; MICRORNA 9 2; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; RACE DIFFERENCE; AGED; COHORT ANALYSIS; GENETIC DATABASE; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DATABASES, GENETIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TRANSCRIPTOME;

EID: 84935021544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128628     Document Type: Article

References (39)

1. Stewart BW, Wild CP. World Cancer Report 2014. Lyon CEDEX, France: The International Agency for Research on Cancer (IARC).
2. Ahmed I, Lobo DN. Malignant tumours of the liver. Surgery (Oxford) 2009; 27: 30-37. doi: 10.1016/j.mpsur.2008.12.005
3. Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R, et al. New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res 2010; 16: 4688-4694. doi: 10.1158/1078-0432.CCR-09-1811 PMID: 20713493
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. doi: 10.1038/nature03702 PMID: 15944708
5. Zhang J, Wang Y, Zhen P, Luo X, Zhang C, Zhou L, et al. Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines. PLoS One 2013; 8: e54111. doi: 10.1371/journal.pone.0054111 PMID: 23359607
6. Vaira V, Roncalli M, Carnaghi C, Faversani A, Maggioni M, Augello C, et al. MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. Liver Int 2015; 35: 1077-1086. doi: 10.1111/liv.12636 PMID: 25040368
7. Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, et al. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene 2014; 533: 389-397. doi: 10.1016/j.gene.2013.09.038 PMID: 24076132
8. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008; 47: 897-907. doi: 10.1002/hep.22160 PMID: 18176954
9. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14: 419-427. doi: 10.1158/1078-0432.CCR-07-0523 PMID: 18223217
10. Barry CT, D'Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, et al. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant 2012; 12: 428-437. doi: 10.1111/j.1600-6143.2011.03788.x PMID: 22008552
11. Zhao Y, Simon R. BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource. Cancer Inform 2008; 6: 9-15. PMID: 19259398
12. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009; 25: 1991-1993. doi: 10.1093/bioinformatics/btp299 PMID: 19435746
13. Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004; 2: E108. doi: 10.1371/journal.pbio.0020108 PMID: 15094809
14. Yan W, Li R, Liu Y, Yang P, Wang Z, Zhang C, et al. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget 2014; 5: 12908-12915. PMID: 25415048
15. Ge YZ, Wu R, Xin H, Zhu M, Lu TZ, Liu H, et al. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol. 2015 (in press) doi: 10.1007/s00432-015-1927-0
16. Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, et al. Serum-based miR-NAs in the prediction and detection of recurrence in melanoma patients. Cancer 2015; 121: 51-59. doi: 10.1002/cncr.28981 PMID: 25155861
17. Gu Y, Zhang M, Peng F, Fang L, Zhang Y, Liang H, et al. The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. Oncotarget 2015; 6: 2397-2406. PMID: 25537514
18. Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, et al. A miRNA signature for defining aggressive phenotype and prognosis in gliomas. PLoS One 2014; 9: e108950. doi: 10.1371/journal.pone.0108950 PMID: 25279461
19. Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, et al. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 2010; 16: 867-875. doi: 10.1158/1078-0432.CCR-09-1840 PMID: 20103675
20. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, et al. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010; 10: 354. doi: 10.1186/1471-2407-10-354 PMID: 20602797
21. Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010; 11: 311-325. doi: 10.2174/138920210791616671 PMID: 21286309
22. Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev 2015; 81: 62-74. doi: 10.1016/j.addr.2014.10.029 PMID: 25450260
23. Trankenschuh W, Puls F, Christgen M, Albat C, Heim A, Poczkaj J, et al. Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS One 2010; 5: e13688. doi: 10.1371/journal.pone.0013688 PMID: 21060828
24. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, et al. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One 2010; 5: e12960. doi: 10.1371/journal.pone.0012960 PMID: 20930934
25. Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, et al. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 2008; 7: 1146-1156. PMID: 18535405
26. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Länger F, et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008; 214: 17-24. doi: 10.1002/path.2251 PMID: 17948228
27. Peters I, Dubrowinskaja N, Abbas M, Seidel C, Kogosov M, Scherer R, et al. DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies. PLoS One 2014; 9: e91440. doi: 10.1371/journal.pone.0091440 PMID: 24633192
28. Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, et al. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer 2013; 133: 660-670. doi: 10.1002/ijc.28068 PMID: 23364900
29. Hong CC, Chen PS, Chiou J, Chiu CF, Yang CY, Hsiao M, et al. miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression. Cancer Res 2014; 74: 6280-6290. doi: 10.1158/0008-5472.CAN-14-0524 PMID: 25205106
30. Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 2013; 30: 373. doi: 10.1007/s12032-012-0373-y PMID: 23292865
31. Cao G, Dong W, Meng X, Liu H, Liao H, Liu S. MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3. Tumour Biol. 2015; (In press). doi: 10.1007/s13277-015-3085-z
32. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51: 846-856. doi: 10.1002/hep.23443 PMID: 20054866
33. Yu H, Lin X, Wang F, Zhang B, Wang W, Shi H, et al. Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells. Oncol Lett 2014; 7: 799-804. doi: 10.3892/ol.2013.1754 PMID: 24520297
34. Lee H, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol 2012; 10: 174. doi: 10.1186/1477-7819-10-174 PMID: 22925189
35. Zhang P, Garnett J, Creighton CJ, Al Sannaa GA, Igram DR, Lazar A, et al. (2014) EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. J Pathol 232: 308-318. doi: 10.1002/path.4294 PMID: 24132643
36. Yang X, Zhong X, Tanyi JL, Shen J, Xu C, Gao P, et al. mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells. Biochem Biophys Res Commun 2013; 431: 617-622. doi: 10.1016/j.bbrc.2012.12.083 PMID: 23274497
37. Wu C, Jin B, Chen L, Zhuo D, Zhang Z, Gong K, et al. MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma. Cell Signal 2013; 25: 1212-1221. doi: 10.1016/j.cellsig.2013.01.028 PMID: 23416459
38. LaCroix B, Gamazon ER, Lenkala D, Im HK, Geeleher P, Ziliak D, et al. Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity. BMC Genomics 2014; 15: 292. doi: 10.1186/1471-2164-15-292 PMID: 24739237
39. Zhuang LP, Meng ZQ. Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival. Biomed Res Int 2015; 2015: 731781. doi: 10.1155/2015/731781 PMID: 25688365